Literature DB >> 10745041

Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13.

K Janssens1, R Gershoni-Baruch, E Van Hul, R Brik, N Guañabens, N Migone, L A Verbruggen, S H Ralston, M Bonduelle, L Van Maldergem, F Vanhoenacker, W Van Hul.   

Abstract

Camurati-Engelmann disease, progressive diaphyseal dysplasia, or diaphyseal dysplasia Camurati-Engelmann is a rare, autosomal dominantly inherited bone disease, characterised by progressive cortical expansion and sclerosis mainly affecting the diaphyses of the long bones associated with cranial hyperostosis. The main clinical features are severe pain in the legs, muscular weakness, and a waddling gait. The underlying cause of this condition remains unknown. In order to localise the disease causing gene, we performed a linkage study in a large Jewish-Iraqi family with 18 affected subjects in four generations. A genome wide search with highly polymorphic markers showed linkage with several markers at chromosome 19q13. A maximum lod score of 4.9 (theta=0) was obtained with markers D19S425 (58.7 cM, 19q13.1) and D19S900 (67.1 cM, 19q13. 2). The disease causing gene is located in a candidate region of approximately 32 cM, flanked by markers D19S868 (55.9 cM, 19q13.1) and D19S571 (87.7 cM, 19q13.4).

Entities:  

Mesh:

Year:  2000        PMID: 10745041      PMCID: PMC1734563          DOI: 10.1136/jmg.37.4.245

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Camurati-Engelmann disease. A case report.

Authors:  J C Hoeffel; L Mainard; B Leyder
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 2.  Sclerosing bone dysplasias--a target-site approach.

Authors:  A Greenspan
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 3.  Heritable metabolic and dysplastic bone diseases.

Authors:  M P Whyte
Journal:  Endocrinol Metab Clin North Am       Date:  1990-03       Impact factor: 4.741

Review 4.  Growth factors and the regulation of bone remodeling.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

6.  Required and nonessential functions of nuclear factor-kappa B in bone cells.

Authors:  B F Boyce; L Xing; G Franzoso; U Siebenlist
Journal:  Bone       Date:  1999-07       Impact factor: 4.398

7.  Progressive diaphyseal dysplasia (Camurati-Engelmann): radiographic follow-up and CT findings.

Authors:  J K Kaftori; U Kleinhaus; Y Naveh
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

8.  Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.

Authors:  F G Wulczyn; M Naumann; C Scheidereit
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

9.  Progressive diaphyseal dysplasia: genetics and clinical and radiologic manifestations.

Authors:  Y Naveh; J K Kaftori; U Alon; J Ben-David; M Berant
Journal:  Pediatrics       Date:  1984-09       Impact factor: 7.124

10.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

Authors:  W S Sly; D Hewett-Emmett; M P Whyte; Y S Yu; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  8 in total

1.  Pain improvement in Camurati-Engelmann disease after anti-TNFα therapy.

Authors:  Sónia Moreira; Bernardo Cunha; Nelson Pedro Jesus; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2017-11-28

Review 2.  Treatment of Ribbing disease with 5-year follow-up and literature review.

Authors:  L L Zhang; W M Jiang; H L Yang; Z-P Luo
Journal:  Osteoporos Int       Date:  2017-01-18       Impact factor: 4.507

Review 3.  Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.

Authors:  K Janssens; F Vanhoenacker; M Bonduelle; L Verbruggen; L Van Maldergem; S Ralston; N Guañabens; N Migone; S Wientroub; M T Divizia; C Bergmann; C Bennett; S Simsek; S Melançon; T Cundy; W Van Hul
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

4.  Camurati-Engelmann disease: imaging, clinical features and differential diagnosis.

Authors:  Aldona Bartuseviciene; Arturas Samuilis; Jovitas Skucas
Journal:  Skeletal Radiol       Date:  2009-02-12       Impact factor: 2.199

5.  Skeletal Dysplasia Presenting as a Neuromuscular Disorder - Report of a Family with Camurati-Engelmann Syndrome.

Authors:  Vasilica Plaiasu; Amalia Costin
Journal:  Maedica (Buchar)       Date:  2015-03

6.  Camurati-Engelmann disease combined with transethmoidal meningoencephalocele: illustrative case.

Authors:  Wataru Yanagihara; Tsukasa Wada; Jun-Ichi Nomura; Hiroaki Saura; Yoshitaka Kubo; Kuniaki Ogasawara
Journal:  J Neurosurg Case Lessons       Date:  2022-02-28

7.  The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.

Authors:  Seo-Jin Park; Choon Sik Yoon; Hui-Wan Park; Jong Rak Choi; Jong Shin Chung; Kyung-A Lee
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

8.  Unusual association between enchondroma and Camurati-Engelmann disease: a case report.

Authors:  Hiroyuki Nagasawa; Kyoji Okada; Hiroshi Nanjo; Hiroshi Sasaki; Shuichi Chida; Yoichi Shimada
Journal:  Ups J Med Sci       Date:  2010-05       Impact factor: 2.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.